Related Experiment Videos
[Functional characterization of microcirculation in tumors: chemotherapeutic implications]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 1, 1985
Summary
Angiotensin II selectively increases tumor blood flow and drug delivery by raising blood pressure. This novel approach enhances chemotherapy effectiveness by targeting tumor microcirculation.
Area of Science:
- Oncology
- Vascular Biology
- Pharmacology
Context:
- Tumor microcirculation exhibits unique hemodynamic properties.
- Selective enhancement of tumor blood flow is a challenge in cancer therapy.
- Understanding tumor vascular function is crucial for drug delivery.
Purpose:
- To investigate the effect of angiotensin II (ATII) on tumor blood flow and microcirculation.
- To explore the potential of ATII-induced hypertension for targeted cancer chemotherapy.
- To analyze microhemodynamic changes in tumor vessels.
Summary:
- Elevating mean arterial blood pressure with angiotensin II (ATII) significantly increased blood flow in tumor tissues, but not in normal tissues.
- ATII administration also enhanced lymph flow from primary tumors to metastatic lymph nodes.
- Advanced microhemodynamic analysis revealed increased vascularity and hydrostatic pressure gradients within tumors.
Impact:
- Demonstrates a novel cancer chemotherapy strategy: ATII-induced hypertension chemotherapy.
- Enhances selective delivery of systemically administered anticancer drugs to tumor tissue.
- Offers a promising approach to improve the efficacy of cancer treatment.